Headline
The latest stories from AHA Today.
AHA podcast: How CommonSpirit Health trustees prioritize and implement community investment strategy
Community investments help foster the social and physical environments that support communities’ long-term health.
The Food and Drug Administration authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at least six months after receiving the initial two-dose series or two months after receiving the single-dose Johnson & Johnson vaccine.
The House of Representatives voted 220-213 to pass a modified version of the Build Back Better Act (H.R. 5376), a roughly $1.75 trillion social spending package that includes many health care provisions.
Leaders at St. Patrick Hospital in Montana say as COVID-19 cases rose, the ages of patients were getting younger and younger.
Houlton Regional Hospital in Maine has shared guidelines on how to safely host holiday get-togethers with friends and families to help prevent COVID-19 and flu from spreading.
In part 2 of this two-part series, Ruby Kirby, CEO of West Tennessee Healthcare Bolivar Hospital and West Tennessee Healthcare Camden Hospital, shares her insights on how rural hospitals and health systems can work with their communities to build confidence in the COVID-19 vaccine, including…
The AHA continues to advocate for rural hospitals and health systems on Capitol Hill and beyond, elevating the most pressing issues facing rural hospitals nationwide.
The AHA has released its next People Matter, Words Matter poster, which can be downloaded, shared and hung in clinical, office or other care settings.
The administration issued an interim final rule requiring health plans to begin submitting annual information next year on prescription drug coverage and spending, including the most frequently dispensed and costliest drugs, and information on prescription drug rebates and their impact on premiums…
The federal government will purchase 10 million treatment courses of the COVID-19 oral antiviral Paxlovid from Pfizer if the Food and Drug Administration approves or authorizes the drug for emergency use, the administration announced.